Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02189343
Title Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed-and-Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acetylon Pharmaceuticals Incorporated
Indications

multiple myeloma

Therapies

Dexamethasone + Pomalidomide + Ricolinostat

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UT Southwestern Medical Center Simmons Comprehensive Cancer Center Dallas Texas 75390-8852 United States Details
CTRC at The UT Health Science Center at San Antonio San Antonio Texas 78229 United States Details
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field